Craig Erickson, MD
Child & Adolescent Psychiatry · Cincinnati, OHNPI 1770789273
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $9,240 of the $9,304 with a category attached, or 99.3%. 5 manufacturers reported payments, led by Mirum Pharmaceuticals, Inc. at 58.0% of the total. 2025 is the largest year on record at $3,600, more than ten times the $36 reported in 2019. Among child & adolescent psychiatry clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 6 payments — averaging $1550.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mirum Pharmaceuticals, Inc.$5K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$2K
- Alkermes, Inc.$2K
- Merck$36
- Impel Pharmaceuticals Inc.$28
Across 34 payments — averaging $7826.91 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$266K
What the payments were for
- Consulting fees$9,24099%
- Food & beverage$641%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mirum Pharmaceuticals, Inc. | 2 | $5,400 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $2,340 |
| Alkermes, Inc. | 1 | $1,500 |
| Merck | 1 | $36 |
| Impel Pharmaceuticals Inc. | 1 | $28 |
How this compares
$9,304 in reported general payments places this provider in the 90th percentile of 160 child & adolescent psychiatry providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuplazidPimavanserin Tartrate | 42 | $211,312 |
| RybelsusSemaglutide | 58 | $58,684 |
| Paliperidone ErPaliperidone | 92 | $33,551 |
| Aripiprazole | 114 | $24,264 |
| MounjaroTirzepatide | 21 | $21,787 |
| Chlorpromazine Hcl | 46 | $20,531 |
| BelsomraSuvorexant | 26 | $12,154 |
| Acamprosate Calcium | 60 | $8,269 |
| Ziprasidone Hcl | 33 | $6,123 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 17 | $5,965 |
| Divalproex Sodium ErDivalproex Sodium | 26 | $2,629 |
| Buspirone Hcl | 25 | $2,391 |
| Fluvoxamine Maleate | 46 | $2,028 |
| Divalproex Sodium | 39 | $1,961 |
| Temazepam | 30 | $1,957 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckBelsomra | $36 | $12,15426 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 160 child & adolescent psychiatry providers in Ohio.
Other child & adolescent psychiatry in Cincinnati
- Melissa DelbelloCincinnati$36K
- Ethan MusgraveCincinnati$3K
- Luis Patino DuranCincinnati$1K
- Jonathan GarrisonCincinnati$1K
- Ernest PedapatiCincinnati$1K
- Joseph CresciCincinnati$911
- Hilton RodriguezCincinnati$649
- Janice SingermanCincinnati$360
- Mark JohnsonCincinnati$336
- Susan MerwinCincinnati$290
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.